Average Co-Inventor Count = 5.75
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gruenenthal Gmbh (36 from 357 patents)
2. Grunenthal Gmbh (8 from 107 patents)
3. Noxxon Pharma Ag (1 from 31 patents)
4. Medifron Dbt Inc. (1 from 1 patent)
46 patents:
1. 10265310 - 6-membered cyclic amines or lactames substituted with urea and phenyl
2. 9775843 - Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders
3. 9771359 - Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II
4. 9624209 - Substituted phenylureas and phenylamides as vanilloid receptor ligands
5. 9284286 - Specific carboxamides as KCNQ2/3 modulators
6. 9278103 - Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
7. 9248122 - Heteroquinoline-3-carboxamides as KCNQ2/3 modulators
8. 9168259 - Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
9. 9120756 - Substituted phenylureas and phenylamides as vanilloid receptor ligands
10. 9108936 - Substituted 4-aminobenzamides as KCNQ2/3 modulators
11. 9073862 - Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators
12. 8946204 - Substituted phenylureas and phenylamides as vanilloid receptor ligands
13. 8937092 - Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands
14. 8791268 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof for treating pain and other conditions
15. 8785474 - Vanilloid receptor ligands, pharmaceutical compositions containing them, process for making them, and use thereof to treat pain and other conditions